US FDA to phase out animal testing in drug development
Go back to US FDA to phase out animal testing in drug development| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 225.52 -0.05 (0.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $225.57 | 52 Week High | $89.18 | |||
| Open | $225.75 | 52 Week Low | $65.70 | |||
| Day High | $226.40 | P/E | 104.89 | |||
| Day Low | $223.08 | EPS | $2.15 | |||
| Volume | 255,811 | |||||
